Resistin levels and inflammatory markers in patients with morbid obesity

Nutricion Hospitalaria

Volumn 25, Issue 4, 2010, Pages 630-634

  De Luis, D A ^a   Gonzalez Sagrado M ^a   Conde, R ^a   Aller, R ^a   Izaola, O ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Inflammatory markers; Morbid obesity; Resistin

Indexed keywords

BIOLOGICAL MARKER; RESISTIN;

ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; FEMALE; HUMAN; INFLAMMATION; MALE; MIDDLE AGED; MORBID OBESITY; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; RISK FACTOR;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY, MORBID; PROSPECTIVE STUDIES; RESISTIN; RISK FACTORS;

EID: 77954789346     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2010.25.4.4478     Document Type: Article

References (29)

1. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 911-919
2. Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin and resistin. Clin Chemistry 2004; 50: 1511-1525
3. De luis DA, González Sagrado M, Conde R, Aller R, Izaola O. Circulating adipocytokines in obese non diabetic patients, relation with cardiovascular risk factors, anthropometry and resting energy expenditure. Ann Nutr Metab 2007; 51: 374-378
4. Matsuda M, Shimomura I, Sata M. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002; 277: 37487-37491
5. Steppan CM, Bailey ST, Bhat S, Brown EJ. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-312
6. Satoh H, Nguyen MT, Miles PD, Immamura T, Usui I, Olefsky JM. Adenovirus-mediated chronic hyper resistinemia leads to in vivo insulin resistance in normal rats. J Clin Investig 2004; 114: 224-231
7. Steppan CM, Lazar MA. The current biology of resistin. J Intern Medicinae 2004: 255: 439-447
8. Sato N, Kobayashi K, Inoguchi T, Sonoda N, Immamura M, Sekiguchi N, Nakashima N, Nawata H. Adenovirus-mediated high expression of resistin causes dyslipemia in mice. Endocrinol 2005; 146: 273-279
9. Muse ED, Obici S, Bhanot S, Monia BP, McKay RA, Rajala MW, Scherr PE, Rossetti L. Role of resistin in diet-induced hepatic insuin resistance. J Clin Invest 2004; 114: 232-239
10. Patel L, Buckles AC, Kinghorn IJ, Murdock PR, Holbrook JD. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activated receptor gamma action in humans. Biochem Biophys Res Commun 2003; 300: 472-476
11. Pagano C, Marin O, Calcagno A, Schiappelli P, Pilon C, Milan G, Bertelli M, Fanin E. Increased serum resistin in adults with Prader Willi syndrome is related to obesity and not to insulin resistance. J Clin Endocrinol and Metab 2005; 90: 4335-4340
12. Burnett MS, Devaney JM, Adenika RJ, Lindsay R, Howard BV. Cross-sectional associations of resistin, coronary heart disease and insulin resistance. J Clin endocr and Metab 2006; 91: 64-68
13. De Luis DA, González Sagrado M, Conde R, Aller R, Izaola A. Relation of resistin levels with cardiovascular risk factors and insulin resistance in non-diabetes obese patients. Diab Res and Clin Res 2009 in press.
14. Zou CC, Liang L, Hong F, Fu JF,Zhao ZY. Serum adiponectin, resistin levels and non alcoholic fatty liver disease in obese children. Endocrine J 2005; 52: 519-524
15. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher Df. Homesotasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-414
16. Lukaski H, Johson PE. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985; 41 (4): 810-817
17. Feurer ID, Mullen JL. Bedside measurement of resting energy expenditure and respiratory quotient via indirect calorimetry. Nutr Clin Pract 1986; 1: 43-49
18. Azuma K, Katsukawa E, Oguchi S, Murata M, Yamazaki H, Shimada A, Saruta A. Correlation between serum resistin level and adiposity in obese individuals. Obesity Research 2003; 11: 997-1001.
19. Pfutzner A, Langenfeld M, Kunt T, Lobig M, Forst T. Evaluation of human resstin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clinical Laboratory 2003; 49: 571-576
20. Iqbal N, Seshadri P, Stern L, Loh J, Kundu S, Jafar T, Samaha FE. Serum resitin is not associated with obesity or insulin resistance in humans. European Rev for medical and Pharmacolocial Sciences 2005; 9: 161-165
21. Norata GD, Ongari M, Garlaschelli K, Raselli S, Grigore L, Catapano L. Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol 2007; 156: 279-284
22. Lehrke M, Reilly M, Millington S, Iqbal N, Rader D, Lazar M. An inflammatory cascade leading to hyperresistinemia in humans. Plos Medicine 2004; 1: 161-168
23. Kunnari A, Ukkola O, Paivansali M, Kesaniemi YA. High plasma resistin level is associated with enhanced hsCRP and leucocytes. Journ Clin Endocrine and Metab 2006; 91: 2755-2760
24. Bo S, Gambino R, Pagani A, Guidi S, Gentile L, Cassader M, Pagano GF: Relationships between human serum resitin inflammatory markers and insulin resistance. Int J Obes 2005; 29: 1315-1320
25. Senolt L, Housa D, Vernerova Z, Jirasek T, Svobodova R, Veigl D, Resistin is abundantly present in rheumatoid arthritis synovial tissue, synovial fluid, and elevated serum resistin reflects disease activity. Ann Rheum Dis 2007; 66: 458-463
26. Qi Q, Wang J, Li H, Yu Z, Ye X, Hu FB, Franco OH, Pan A, Liu Y, Lin X. Associations of resistin with inflammatory and fibrinolytic markers, insulin resistance, and metabolic syndrome in middle-aged and older Chinese. Eur J Endocrinol 2008; 159: 585-593
27. Chu N, Kong APS, Kim DD, AMstrond D, Baxi S, Deustch R, Caulfield M, Mudallar SR, Reitz R, Henry RR. Differential effects of metformin and troglitaznoe on cardiovascular risk factors in patients with DM2. Diabet Care 2002; 25: 542-548
28. Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 2003; 108 (6): 736-740
29. Zhang JL, Qiin YW, Zheng X. The relationship between human serum resistin level and body fat content, plasma glucose as well as blood pressure. Nat Med J China 2002; 82: 1609-1612